These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor. Shibuya M FEBS J; 2009 Sep; 276(17):4636-43. PubMed ID: 19664071 [TBL] [Abstract][Full Text] [Related]
23. Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells. Gale NW; Baluk P; Pan L; Kwan M; Holash J; DeChiara TM; McDonald DM; Yancopoulos GD Dev Biol; 2001 Feb; 230(2):151-60. PubMed ID: 11161569 [TBL] [Abstract][Full Text] [Related]
24. The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway. Noren NK; Foos G; Hauser CA; Pasquale EB Nat Cell Biol; 2006 Aug; 8(8):815-25. PubMed ID: 16862147 [TBL] [Abstract][Full Text] [Related]
31. Attenuation of ephrinB2 reverse signaling decreases vascularized area and preretinal vascular tuft formation in the murine model of oxygen-induced retinopathy. Taylor AC; Mendel TA; Mason KE; Degen KE; Yates PA; Peirce SM Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5462-70. PubMed ID: 22789927 [TBL] [Abstract][Full Text] [Related]
32. Altered expression patterns of EphrinB2 and EphB2 in human umbilical vessels and congenital venous malformations. Diehl S; Bruno R; Wilkinson GA; Loose DA; Wilting J; Schweigerer L; Klein R Pediatr Res; 2005 Apr; 57(4):537-44. PubMed ID: 15718372 [TBL] [Abstract][Full Text] [Related]
33. Multitargeting strategy using lenvatinib and golvatinib: maximizing anti-angiogenesis activity in a preclinical cancer model. Nakazawa Y; Kawano S; Matsui J; Funahashi Y; Tohyama O; Muto H; Nakagawa T; Matsushima T Cancer Sci; 2015 Feb; 106(2):201-7. PubMed ID: 25458359 [TBL] [Abstract][Full Text] [Related]
35. EphrinB2/EphB4 pathway in postnatal angiogenesis: a potential therapeutic target for ischemic cardiovascular disease. Yang D; Jin C; Ma H; Huang M; Shi GP; Wang J; Xiang M Angiogenesis; 2016 Jul; 19(3):297-309. PubMed ID: 27216867 [TBL] [Abstract][Full Text] [Related]
36. Selective blockade of vascular endothelial growth factor receptor 2 with an antibody against tumor-derived vascular endothelial growth factor controls the growth of human pancreatic adenocarcinoma xenografts. Holloway SE; Beck AW; Shivakumar L; Shih J; Fleming JB; Brekken RA Ann Surg Oncol; 2006 Aug; 13(8):1145-55. PubMed ID: 16791450 [TBL] [Abstract][Full Text] [Related]
37. Endosialin/TEM 1/CD248 is a pericyte marker of embryonic and tumor neovascularization. Bagley RG; Honma N; Weber W; Boutin P; Rouleau C; Shankara S; Kataoka S; Ishida I; Roberts BL; Teicher BA Microvasc Res; 2008 Nov; 76(3):180-8. PubMed ID: 18761022 [TBL] [Abstract][Full Text] [Related]
38. Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes. Aghi M; Cohen KS; Klein RJ; Scadden DT; Chiocca EA Cancer Res; 2006 Sep; 66(18):9054-64. PubMed ID: 16982747 [TBL] [Abstract][Full Text] [Related]
39. EphrinB2-EphB4 signalling provides Rho-mediated homeostatic control of lymphatic endothelial cell junction integrity. Frye M; Stritt S; Ortsäter H; Hernandez Vasquez M; Kaakinen M; Vicente A; Wiseman J; Eklund L; Martínez-Torrecuadrada JL; Vestweber D; Mäkinen T Elife; 2020 Sep; 9():. PubMed ID: 32897857 [TBL] [Abstract][Full Text] [Related]
40. Generation of transgenic mice overexpressing EfnB2 in endothelial cells. Luxey M; Laussu J; Jungas T; Davy A Genesis; 2011 Oct; 49(10):811-20. PubMed ID: 21735541 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]